A detailed history of Cormorant Asset Management, LP transactions in Gh Research PLC stock. As of the latest transaction made, Cormorant Asset Management, LP holds 593,043 shares of GHRS stock, worth $4.06 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
593,043
Previous 593,043 -0.0%
Holding current value
$4.06 Million
Previous $6.91 Million 42.62%
% of portfolio
0.28%
Previous 0.53%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$10.15 - $16.15 $153,062 - $243,541
-15,080 Reduced 2.48%
593,043 $6.89 Million
Q2 2021

Aug 16, 2021

BUY
$19.25 - $21.73 $11.7 Million - $13.2 Million
608,123 New
608,123 $12.6 Million

Others Institutions Holding GHRS

About GH Research PLC


  • Ticker GHRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,020,800
  • Market Cap $356M
  • Description
  • GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders. The company focuses on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH0...
More about GHRS
Track This Portfolio

Track Cormorant Asset Management, LP Portfolio

Follow Cormorant Asset Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Cormorant Asset Management, LP with notifications on news.